Resolution of Longstanding Symptoms of Multiple Sclerosis by Application of Picotesla Range Magnetic Fields

References

• Adams R. D., Victor M. Principles of neurology. McGraw-Hill Book Company, New York 1985; 699–717
   Google Scholar
• Adey W. R. Tissue interactions with nonionizing electromagnetic fields. Physiological Reviews 1981; 61: 435–513
   PubMed Web of Science ®Google Scholar
• Alta J. F., Bennet El. R., Anderson R. E. Cranial CT appearance of acute multiple sclerosis. Neurology 1978; 28: 251–255
   PubMedGoogle Scholar
• Bardasano J. L., Meyer A. J., Picazo L. Ultrastructure of the pineal cells of the homing pigion Columba livia and magnetic fields (first trials). Journal fuer Hirnforschung 1985; 26: 471–475
   PubMedGoogle Scholar
• Bawin S. M., Adey W. R., Sabbot I. M. Ionic factors in the release of 45Ca2+ from chicken cerebral tissue by electromagnetic fields. Proceedings of the National Academy of Science USA 1978; 75: 6314–6318
   PubMed Web of Science ®Google Scholar
• Blackman C. F., Benane S. G., House D. E., Joines W. T. Effects of ELF (1–120 Hz) and modulated (50 Hz) RF fields on the efflux of calcium ions from brain tissue in vitro. Bioelectromagnetics 1985; 6: 1–11
   PubMed Web of Science ®Google Scholar
• Bernstein M. B. Textbook of immunopathology: central nervous system. Grune & Stratton Inc, New York 1968; 507–515
   Google Scholar
• Carnegie P. R. Relationship of methylarginine to the main encephalitogenic determinant and some speculative implications for multiple sclerosis. Multiple sclerosis progress in research, E. J. Field, T. M. Bell, P. R. Carnegie. North Holland Publishing, Amsterdam 1972; 63–69
   Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Cremer-Bartels G., Krause K., Kuechle H. J. Influence of low magnetic-field strength variations on the retina and pineal gland of quails and humans. Graefe's Archives of Clinical and Experimental Ophthalmology 1983; 220: 248–252
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Davis F. A. Pathophysiology of multiple sclerosis and related clinical implications. Modern Treatment 1970; 7: 890–902
   PubMedGoogle Scholar
• Demaine C., Semrn P. The avian pineal gland as an independent magnetic sensor. Neuroscience Letters 1985; 62: 119–122
   PubMed Web of Science ®Google Scholar
• Frick E., Scheid-Seydel L. Untersuchungen mit Markirtem Globulin zur Frage der Abstam-mung der Liquoreiweisskorper. Klinische Wochenschrift 1958; 36: 857–863
   PubMedGoogle Scholar
• Georgi W. Multiple sclerose: pathologische-anatomische befunde multiple sclerose bei klinisch nicht diagnostizierten krankheiten. Schweizerischer Medizinische Wochenschrift 1961; 91: 605–607
   PubMedGoogle Scholar
• Ghatak N. R., Hirano A., Lijtmaer H., Zimmerman H. M. Asymptomatic demyelinated plaque in the spinal cord. Archives of Neurology 1974; 30: 484–486
   PubMedGoogle Scholar
• Gilbert J. J., Sadler M. Unsuspected multiple sclerosis. Archives of Neurology 1983; 40: 533–536
   PubMedGoogle Scholar
• Halliday A. M., McDonald W. I. Pathophysiology of demyelinating disease. British Medical Bulletin 1977; 33: 21–27
   PubMed Web of Science ®Google Scholar
• Harrer G., Fischbach R. Uber die wirkung bestimmter aminosauren auf das ergebniss des unberwarmungstests bein multiple sclerose kranken. Journal of Neural Transmission 1973; 34: 205–214
   PubMed Web of Science ®Google Scholar
• Holder G. E., Bartlett J. R., Bridges P. K., Kantamanei B. D., Curzon G. Correlation between transmitter metabolite concentrations in human ventricular cerebrospinal fluid and pattern visual evoked potentials. Brain Research 1980; 188: 582–586
   PubMed Web of Science ®Google Scholar
• Hyyppa M. T., Jolma T., Riekkinen P., Rinne U. K. Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Jacobs L., Kinkel P. R., Kinkel W. R. Silent brain lesions in patients with isolated optic neuritis. Archives of Neurology 1986; 43: 452–455
   PubMedGoogle Scholar
• Johansson B., Ross B. E. 5-hydroxyindoleacetic acid and homovanillic acid in CSF of patients with neurological disease. European Neurology 1977; 11: 37–45
   Web of Science ®Google Scholar
• Kavaliers M., Ossenkopp K. P. Magnetic fields inhibition of morphine-induccd analgesia and behavioral activity in mice: evidence for involvement of calcium ions. Brain Research 1986; 379: 830–838
   Web of Science ®Google Scholar
• Kirk A., Kertesz A. On drawing impairment in Alzheimer's disease. Archives of Neurology 1991; 48: 73–77
   PubMed Web of Science ®Google Scholar
• Kisser W., Harrer G. Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Koopmans R. A., Li D. K. R., Oger J. J. F., Mayo J., Paly D. W. The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology 1989; 39: 959–963
   PubMed Web of Science ®Google Scholar
• Koya G., Suzuki M., Baba M., Iwabuchi T. An autopsy case of concurrence of multiple selerosis and glioma. Hirosaki Medical Journal 1977; 29: 588–596
   Google Scholar
• Lennon V. A., Carnegie P. R. Immunopharmacological disease: a break in tolerance to receptor sites. Lancet 1971; 2: 630–633
   Google Scholar
• Lynch D. K. B., Mayo J., Fache S., Robertson W., Lastrukoff L. F., Oger I., Paty D. W. Lack of correlation between clinical manifestations and lesions of MS as seen by NMR. Neurology 1984; 34: 136, (suppl)
   PubMedGoogle Scholar
• Lynch S. G., Rose J. W., Smoker W., Petajan J. H. MRI in tamilial multiple sclerosis. Neurology 1990; 40: 900–903
   PubMed Web of Science ®Google Scholar
• MackKay R. P., Hirano A. Forms of benign multiple sclerosis: report of two clinicaly silent cases discovered at autopsy. Archives of Nenrosience 1967; 17: 588–600
   Google Scholar
• McDonald W. I., Barnes D. Lesson from magnetic resonance imaging in multiple sclerosis. Trends in Neuroscience 1989; 12: 376–379
   PubMed Web of Science ®Google Scholar
• McDonald W. I. Pathophysiology of conduction in central nerve fibres. Visual rvoked potentials in man: new developments, J. Desmcdt. Claredon Press, Oxford 1977; 423–437
   Google Scholar
• McFarlin D. E., McFarland H. Multiple sclerosis. New England Journal of Medicine 1982; 307: 1183–1188
   PubMed Web of Science ®Google Scholar
• Morariu M., Klutzow W. F. Subclinical multiple sclerosis. Journal of Medicine 1976; 213: 71–76
   Google Scholar
• Namerow N. S., Thompson L. B. Plaques, symptoms, and the remitting course of multiple sclerosis. Neurology 1969; 19: 765–774
   PubMedGoogle Scholar
• Olcese J., Reuss S. Magnetic field effects on pineal gland melatonin synthesis: comparativc studies on albino and pigmented rodents. Brain Research 1986; 365: 365–368
   PubMedGoogle Scholar
• Oleese J., Reuss S., Semm P. Geomagnetic field detection in rodent. Life Sciences 1988; 42: 605–613
   PubMedGoogle Scholar
• Olcesc J., Reuss S., Stehle S., Steinlechner S., Vollrath L. The mammalian pineal and retinae as geomagnetic field detectors. Fundamentals and clinics in pineal research, G. P. Trentini, C. DeGaetani, P. Pevet. Raven Press, New York 1987; Vol 44: 79–82
   Google Scholar
• Onotrj M., Bazzano S., Malatesta G., Gambi D. Pathophysiology of delayed evoked potentials in multiple sclerosis. Functional Neurology 1990; 5: 301–319
   PubMedGoogle Scholar
• Ormerod I. E. C. du, Boulay G. H., McDonald W. I. Imaging of multiple sclerosis. Multiple scleroses, W. I. McDonald, D. H. Silberg. Butterworths, London 1986; 11–36
   Google Scholar
• Phadke J. G., Best P. V. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 414–420
   PubMed Web of Science ®Google Scholar
• Poser C. M. Multiple sclerosis. Observations and reflections–a personal memoir. Journal of the Neurological Sciences 1992; 107: 127–140
   PubMed Web of Science ®Google Scholar
• Prineas J. W. The etiology and pathogenesis of multiple sclerosis. Multiple sclerosis and other demyelinating diseases, P. J. Vinken, G. W. Bruyn. North Holland, Amsterdam 1970; 107–160
   Google Scholar
• Rao N. A. Chronic experimcntal allergic optic neuritis. Investigative Ophthalmology and Visual Sciences 1981; 20: 159–172
   PubMed Web of Science ®Google Scholar
• Rozenewaig R., Grad B. R., Ochoa J. The role of melatonin and serotonin in aging. Medical Hypotheses 1987; 23: 337–352
   PubMedGoogle Scholar
• Rudolph K., Wirz-Justice A., Krauchi K., Feer H. Static magnetic fields decrease nocturnal pineal CAMP in the rat. Brain Research 1988; 446: 159–160
   PubMed Web of Science ®Google Scholar
• Sandyk K. Coexisting bipolar affective disorder and multiple selerosis: The role of the pineal gland. International Journal of Neuroscience 1991; 59: 267–270
   PubMed Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992; 66(1)237–250
   PubMedGoogle Scholar
• Sandyk R. The pineal gland and multiple selerosis. (Editorial). International Journal of Neuroscience 1992b; 63: 206–215
   Web of Science ®Google Scholar
• Sandyk R. The pineal gland and the clinical course of multiple sclerosis. International Journal of Neuroscience 1992c; 62: 65–74
   PubMed Web of Science ®Google Scholar
• Sandyk R. Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience, (in press)
   Google Scholar
• Sandyk R., Awerbuch G. I. The pineal gland in multiple sclerosis. International Journal of Neuroscience 1991; 61: 61–67
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience 1992; 67: 173–186
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience 1993; 68: 227–240
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience 1993; 68: 241–253
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience, (in press)
   Google Scholar
• Sandyk R., Iacono R. P. Improvement of visuoperceptive functions in multiple sclerosis by picoTesla range magnetic fields. International Journal of Neuroscience, (in press)
   Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeors. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth-strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Semm P., Schneider T., Vollrath L. Effects of an earth-strength magnetic field on electrical activity of pineal cells. Nature 1980; 288: 607–608
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Growth hormone response to melatonin in man. Science 1974; 184: 1373–1374
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Suppression of HGH secretion by melatonin and cyproheptadine. Journal of Clinical Investigations 1974; 54: 116–121
   PubMed Web of Science ®Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Vost A., Wolochow D. A., Howell D. A. Incidence of infarcts of the brain in heart disease. Journal of Pathology & Bacteriology 1964; 88: 463–470
   PubMedGoogle Scholar
• Vuia 0. The benign form of multiple sclerosis: anatomo-clinical aspects. Acta Neurologica Scandinavica 1977; 55: 289–293
   PubMed Web of Science ®Google Scholar
• Waxman S. G. Clinical course and electrophysiology of multiple sclerosis. Advances in neurology. Functional recovery in neurological disease, S. G. Waxman. Raven Press, New York 1988; Vol. 47: 157–184
   Google Scholar
• Waksman B. H., Reynolds W. E. Multiple sclerosis as a disease of immune regulation. Proceedings of the Society of Experimental Biology and Medicine 1984; 175: 282–294
   PubMed Web of Science ®Google Scholar
• Weiner H. L., Hauser S. L. Neuroimmunology. I: Immunoregulation in neurological disease. Annals of Neurology 1982; 11: 437–449
   PubMed Web of Science ®Google Scholar
• Welker H. A., Semrn P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Anderson L. E., Hilton D. I., Phillips R. D. Chronic exposure to 60-Hz electric fields: effects on pineal function in the rat. Bioelectromagnetics 1981; 2: 371–380
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Chess E. K., Anderson L. E. 60-Hz electric-field effects on pineal melatonin rhythms: time course for onset and recovery. Bioelectromagnetics 1986; 7: 239–242
   PubMed Web of Science ®Google Scholar
• Wisniewski H. M., Keith A. B. Chronic relapsing experimental allergic encephalomyelitis: An experimental model of multiple sclerosis. Annals of Neurology 1977; I: 144–148
   Google Scholar